Search the Newsroom
Filter By
Showing 2751 - 2760 of 2969 results
New Drug May Overcome Treatment Resistance in a High-risk Children’s Cancer
CHOP researchers have identified a powerful new drug with “unparalleled” strength against refractory types of neuroblastoma.
Historic Double Hand Transplant
Zion Harvey received a double hand transplant at The Children's Hospital of Philadelphia — first child to undergo this procedure. Zion received OT and PT several times a day during his recovery.
Pediatric Neuro-ophthalmologist Robert A. Avery, DO, MSCE, Joins Division of Ophthalmology
The Children's Hospital of Philadelphia’s Division of Pediatric Ophthalmology welcomes neuro-ophthalmologist Robert A. Avery, DO, MSCE.
Gaps in Care for Child Trauma and Stress after Injury
An international survey finds gap in knowledge when dealing with child traumatic stress.
The Children’s Hospital of Philadelphia Participates in Spark Therapeutics Public Offering
Spark Therapeutics, Inc. recently announced a public offering issuing two-million primary shares at $47.00 per share. Included in the sale as a secondary offering are one-million shares, at $47.00, held by CHOP.
The Children’s Hospital of Philadelphia Chooses New Chief Operating Officer
The Children’s Hospital of Philadelphia has chosen Douglas G. Hock as its new executive vice president and chief operating officer, beginning on Feb. 1.
Grant to CHOP Funds Personalized Treatments for Children with Neuroblastoma
A $1.5 million grant to CHOP from Alex’s Lemonade Stand Foundation supports an innovative treatment for children with high-risk neuroblastoma.
Zion’s Story - Double Hand Transplant
By any measure, 8-year-old Zion Harvey has led an extraordinary life. At the age of 2, he developed sepsis, a life-threatening infection that led to the amputation of his feet and hands. The illness also damaged his kidneys and, two years later, Zion underwent a kidney transplant — receiving an organ donated by his mother, Pattie Ray.
When Parents Say 'No' to Vaccines
A primary care pediatrician in the CHOP Care Network Roxborough practice reflects on addressing the powerful emotions families sometimes display during vaccine conversations.
Why Do Children Develop Cancer?
CHOP’s Dr. John Maris comments on a just-published major study of genes that raise a child’s risk for cancer, and what this means for counseling families and patients.